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The effect of the N-alkyl moiety on the interaction of pindolol analogues 
with the two agonist conformations of the human β1-adrenoceptor 
 
There are two active conformations of the β1-adrenoceptor (AR): a high affinity conformation 
(HAC) where responses are readily inhibited by antagonists and a low affinity conformation 
where agonist responses are relatively resistant to antagonism (1). Some ligands, e.g. 
pindolol, stimulate both conformations (2). Analogues of pindolol were synthesised to 
examine the contribution of the N-alkyl moiety to activation at each conformation of the 
human β1-AR. 3H-CGP 12177 whole cell binding and CRE-SPAP reporter gene assay were 
examined in cells stably expressing the human β1-AR as previously described (2). 
 
 
 
 R1/R2 Log KD n Log EC501 Log EC502 % site 1 % isop max n
pindolol  -8.67±0.04 7 -8.86±0.18 -6.32±0.32 51.6±3.6 74.8±10.2 6 
1a  -9.40±0.04 10 -9.16±0.11 -6.51±0.13 55.8±4.3 77.0±5.4 8 
1b H -7.70±0.04 6 -8.16±0.08 -5.84±0.12 56.5±7.5 69.6±4.2 6 
1c  -7.78±0.05 6 -8.21±0.09 -5.69±0.19 43.2±6.5 64.6±5.3 8 
1d  -8.77±0.04 6 -8.96±0.13 -6.39±0.20 50.0±3.5 67.2±7.3 9 
1e  -8.37±0.03 6 -8.50±0.10 -5.92±0.09 48.5±3.5 70.2±5.9 8 
1f  -8.26±0.04 5 -8.41±0.07 -5.88±0.08 44.6±3.4 71.5±8.1 7 
1g  -9.82±0.04 10 -9.19±0.14 -6.70±0.34 65.0±4.5 83.2±6.5 8 
1h  -8.74±0.04 6 -8.84±0.10 -6.25±0.10 42.7±3.2 72.7±5.1 8 
1i  -8.40±0.06 6 -8.93±0.09 -6.35±0.12 58.3±4.1 73.9±7.1 7 
1j  -8.30±0.06 6 -8.45±0.05 -6.01±0.08 41.8±3.0 76.1±7.7 8 
1k  -9.01±0.05 9 -9.09±0.08 -6.38±0.30 58.2±7.1 81.1±9.2 6 
1l  -7.64±0.03 6 -8.05±0.06 -6.01±0.08 53.4±5.8 66.7±9.7 6 
1m 
 
-9.54±0.05 6 -9.62±0.11 -6.99±0.21 64.2±6.4 72.7±6.9 7 
2a H No binding 4 No response    8 
2b  No binding 4 No response    8 
 
Table. Log KD values from 3H-CGP12177 binding and log EC50 values and % maximum 
isoprenaline responses from CRE-SPAP production. Values are mean±sem of n separate 
experiments 
 
 
Ligand affinity for the HAC was affected by the nature of the N-alkyl moiety. Whilst an amine 
moiety was essential for receptor interaction, sterically small amine groups (e.g. 1b, 1c) gave 
lower affinity. Steric bulk near to the amine or a distant aromatic group, maintained high 
affinity for the HAC in addition to agonist activity at both conformations (1a, 1g, 1h, 1k, 1m).  
The nature of the N-alkyl moiety does not appear of importance in agonist stimulation at either 
conformation of the β1-AR.  
 
(1) Kaumann and Molenaar (2008). Pharmacol. Ther. 118: 303–336. 
(2) Baker et al. (2003). Mol. Pharmacol. 63: 1312–1321. 
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